Unknown

Dataset Information

0

Cellular Imprinting Proteomics Assay: A Novel Method for Detection of Neural and Ocular Disorders Applied to Congenital Zika Virus Syndrome.


ABSTRACT: Congenital Zika syndrome was first described due to increased incidence of congenital abnormalities associated with Zika virus (ZIKV) infection. Since the eye develops as part of the embryo central nervous system (CNS) structure, it becomes a specialized compartment able to display symptoms of neurodegenerative diseases and has been proposed as a noninvasive approach to the early diagnosis of neurological diseases. Ocular lesions result from defects that occurred during embryogenesis and can become apparent in newborns exposed to ZIKV. Furthermore, the absence of microcephaly cannot exclude the occurrence of ocular lesions and other CNS manifestations. Considering the need for surveillance of newborns and infants with possible congenital exposure, we developed a method termed cellular imprinting proteomic assay (CImPA) to evaluate the ocular surface proteome specific to infants exposed to ZIKV during gestation compared to nonexposure. CImPA combines surface cells and fluid capture using membrane disks and a large-scale quantitative proteomics approach, which allowed the first-time report of molecular alterations such as neutrophil degranulation, cell death signaling, ocular and neurological pathways, which are associated with ZIKV infection with and without the development of congenital Zika syndrome, CZS. Particularly, infants exposed to ZIKV during gestation and without early clinical symptoms could be detected using the CImPA method. Lastly, this methodology has broad applicability as it could be translated in the study of several neurological diseases to identify novel diagnostic biomarkers. Data are available via ProteomeXchange with identifier PXD014038.

SUBMITTER: Rosa-Fernandes L 

PROVIDER: S-EPMC7640952 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cellular Imprinting Proteomics Assay: A Novel Method for Detection of Neural and Ocular Disorders Applied to Congenital Zika Virus Syndrome.

Rosa-Fernandes Livia L   Barbosa Raquel Hora RH   Dos Santos Maria Luiza B MLB   Angeli Claudia B CB   Silva Thiago P TP   Melo Rossana C N RCN   de Oliveira Gilberto Santos GS   Lemos Bernardo B   Van Eyk Jennifer E JE   Larsen Martin R MR   Cardoso Claudete Araújo CA   Palmisano Giuseppe G  

Journal of proteome research 20200804 11


Congenital Zika syndrome was first described due to increased incidence of congenital abnormalities associated with Zika virus (ZIKV) infection. Since the eye develops as part of the embryo central nervous system (CNS) structure, it becomes a specialized compartment able to display symptoms of neurodegenerative diseases and has been proposed as a noninvasive approach to the early diagnosis of neurological diseases. Ocular lesions result from defects that occurred during embryogenesis and can bec  ...[more]

Similar Datasets

2020-07-23 | PXD014038 | Pride
| S-EPMC5335843 | biostudies-literature
| S-EPMC7846595 | biostudies-literature
| S-EPMC5790226 | biostudies-literature
| S-EPMC4650860 | biostudies-literature
| S-EPMC5839592 | biostudies-literature
2024-01-18 | GSE234062 | GEO
| S-EPMC5444996 | biostudies-other
2022-07-01 | GSE198925 | GEO
| PRJNA817519 | ENA